CDKN2B-AS1 and renal cell carcinoma: ANRIL is highly expressed in human RCC tissues and RCC cell lines, and significantly promotes RCC cell proliferation, migration, invasion and epithelial-to-mesenchymal transition (EMT) [6] (Table 1).